Upcoming Events

European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
Saturday, April 21 2018 - Tuesday, April 24 2018

Madrid, Spain

Fourteen poster presentations, including four oral sessions, will feature VenatoRx's lead clinical antibacterial candidate, cefepime/VNRX-5133, at ECCMID in Madrid, Spain. In addition, VenatoRx’s President and CEO, Christopher J. Burns, Ph.D., will present a brief overview about the Company’s R&D pipeline during Pipeline Corner on April 23, 2013 beginning at 12:30pm CET in Hall Y.

Clinical Leader Forum
Wednesday, May 09 2018 - Thursday, May 10 2018

Philadelphia, PA

American Society for Microbiology (ASM) Microbe 2018
Thursday, June 07 2018 - Monday, June 11 2018

Atlanta, GA

ID Week
Wednesday, October 03 2018 - Sunday, October 07 2018

San Francisco, CA

Archive: 2018